Keyphrases
Indonesia
100%
Falciparum Malaria
87%
Primaquine
83%
Plasmodium Vivax
79%
Plasmodium Falciparum
48%
Malaria
47%
Individual Patient Data Meta-analysis
38%
Radical Cure
36%
Chloroquine
23%
Antimalarial Resistance
23%
Resistance Network
23%
Randomized Placebo-controlled Trial
21%
Surface Antigen
19%
Systematic Meta-analysis
17%
Glucose-6-phosphate Dehydrogenase (G6PD)
17%
Parasitemia
17%
Irian Jaya
17%
Malaria Control
17%
Dihydroartemisinin-piperaquine
16%
Meta-analysis
14%
Filarial Parasites
14%
Co-epidemics
14%
Randomized Controlled Trial
13%
Artemisinin-based Combination Therapy
13%
Wuchereria Bancrofti
13%
Artemether-lumefantrine
13%
Hyperendemic Areas
12%
Permethrin
12%
Bed Nets
12%
Gametocyte Carriage
12%
Eastern Indonesia
12%
Glucose-6-phosphate Dehydrogenase Activity
11%
Brugia Malayi
11%
Confidence Interval
11%
Lymphatics
10%
West Timor
10%
Filarial Nematodes
10%
Short Course
9%
Recrudescence
9%
Secreted Antigens
9%
Brugia
9%
Severe Malaria
9%
Schoolchildren
9%
Individual Participant Data Meta-analysis
8%
Brugia Pahangi
8%
PRIMA
8%
Cluster Randomized Trial
8%
Spectrophotometry
8%
Mass Treatment
8%
Jakarta
8%
Pharmacology, Toxicology and Pharmaceutical Science
Primaquine
84%
Plasmodium Vivax Malaria
56%
Malaria Falciparum
52%
Plasmodium vivax
45%
Antimalarial Agent
33%
Recurrent Disease
27%
Placebo
25%
Parasitemia
24%
Chloroquine
24%
Piperaquine
21%
Combination Therapy
20%
Glucose 6 Phosphate Dehydrogenase
20%
Artemisinin
20%
Plasmodium falciparum
18%
Dihydroartemisinin
15%
Infection
14%
Randomized Controlled Trial
14%
Adverse Event
12%
Artemether Plus Benflumetol
12%
Clinical Trial
9%
Pyrimethamine Plus Sulfadoxine
8%
Anemia
8%
Plasmodium
7%
Drug Resistance
7%
Albendazole
6%
Helminthiasis
6%
Diseases
6%
Artesunate
6%
Anorexia
6%
Treatment Group
5%
Prevalence
5%
Open-Label Trial
5%
Efficacy Study
5%